Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Castello

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reactionGiuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
International Journal of Oncology|May 10, 2003
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative GroupPaolo A Ascierto, Giuseppe Palmieri, Gerardo Botti, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesisFrancesco Izzo, Maurizio Montella, Antonio Pio Orlando, et al.
Journal of Translational Medicine|August 18, 2010
Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatmentPaolo A Ascierto, Maria Napolitano, Egidio Celentano, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2006
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South ItalyMilena Casula, Maria Colombino, Maria P Satta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Human melanoma metastases express functional CXCR4Stefania Scala, Paola Giuliano, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studiesPaolo A Ascierto, Stefania Scala, Giuseppe Castello, et al.
Cell Cycle (Georgetown, Tex.)|December 4, 2010
Differential role of CD133 and CXCR4 in renal cell carcinomaCrescenzo D'Alterio, Luca Cindolo, Luigi Portella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patientsAlessandro Ottaiano, Renato Franco, Annarita Aiello Talamanca, et al.
Clinical Genetics|December 28, 2020
IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?Diego Lopergolo, Flavia Privitera, Giuseppe Castello, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reactionGiuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
International Journal of Oncology|May 10, 2003
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative GroupPaolo A Ascierto, Giuseppe Palmieri, Gerardo Botti, et al.
Journal of Gastroenterology and Hepatology|January 5, 2007
Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesisFrancesco Izzo, Maurizio Montella, Antonio Pio Orlando, et al.
Journal of Translational Medicine|August 18, 2010
Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatmentPaolo A Ascierto, Maria Napolitano, Egidio Celentano, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2006
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South ItalyMilena Casula, Maria Colombino, Maria P Satta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Human melanoma metastases express functional CXCR4Stefania Scala, Paola Giuliano, Paolo A Ascierto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studiesPaolo A Ascierto, Stefania Scala, Giuseppe Castello, et al.
Cell Cycle (Georgetown, Tex.)|December 4, 2010
Differential role of CD133 and CXCR4 in renal cell carcinomaCrescenzo D'Alterio, Luca Cindolo, Luigi Portella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patientsAlessandro Ottaiano, Renato Franco, Annarita Aiello Talamanca, et al.
Clinical Genetics|December 28, 2020
IQSEC2 disorder: A new disease entity or a Rett spectrum continuum?Diego Lopergolo, Flavia Privitera, Giuseppe Castello, et al.
Pageof 9